Literature DB >> 14979944

Anti-inflammatory effect of erythromycin on histamine-induced otitis media with effusion in guinea pigs.

Bülent Aktan1, Cemal Gundogdu, Harun Ucuncu, Bunyami Unal, Yavuz Sütbeyaz, Sare Altas.   

Abstract

In this study, the anti-inflammatory effect of erythromycin was investigated in a model of histamine-induced otitis media with effusion (OME). OME was induced in guinea pigs by the transtympanic injection of histamine solution into the middle-ear cavity. Guinea pigs were randomly assigned to one of three groups: control, erythromycin treatment, or methylprednisolone treatment. After histamine injection, the animals were treated with intraperitoneal medication for five days consecutively. Afterwards, the animals were sacrificed and the temporal bones were removed. The samples were examined stereologically. In the erythromycin-treated group, it was observed that neutrophil infiltration was significantly inhibited when compared to the control group. This result shows that erythromycin may produce a significant anti-inflammatory effect in this model of OME.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14979944     DOI: 10.1258/002221504772784522

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  3 in total

1.  Serum paraoxonase and arylesterase activities in patients with chronic otitis media.

Authors:  Mahfuz Turan; Rıfkı Ucler; Mehmet Aslan; Ferhat Kalkan; Abdullah Taskın; Mehmet Fatih Garca; Hakan Cankaya
Journal:  Redox Rep       Date:  2015-05-13       Impact factor: 4.412

2.  Oxidative stress in chronic otitis media.

Authors:  Elif Baysal; Nurten Aksoy; Ferit Kara; Seyithan Taysi; Abdullah Taşkın; Hasan Bilinç; Cengiz Cevik; Fatih Celenk; Muzaffer Kanlıkama
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-06-19       Impact factor: 2.503

3.  The evaluation of oxidative stress in the serum and tissue specimens of patients with chronic otitis media.

Authors:  Mehmet Fatih Garça; Mahfuz Turan; Barış Avşar; Ferhat Kalkan; Halit Demir; Ahmet Kozan; Nazım Bozan
Journal:  Clin Exp Otorhinolaryngol       Date:  2015-05-13       Impact factor: 3.372

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.